Terumo Corporation

corporate_venture

Profile

Headquarters
Tokyo, Japan
Investments
2
Companies
1

Capital

Total Deployed
$144M
Lead Rounds
0
Website
www.terumo.com

Portfolio

1 company
Orchestra BioMed $185M
Public New Hope, United States

Orchestra BioMed is a biomedical innovation company that accelerates high-impact medical technologies through risk-reward sharing partnerships with leading medical device companies. Its lead programs are BackBeat Cardiac Neuromodulation Therapy for hypertension treatment in pacemaker patients and Virtue Sirolimus AngioInfusion Balloon for atherosclerotic artery disease. The company has strategic partnerships with Medtronic and Terumo Corporation.

Investment data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.